163 related articles for article (PubMed ID: 24517923)
21. Modifications on amphiphilicity and cationicity of unnatural amino acid containing peptides for the improvement of antimicrobial activity against pathogenic bacteria.
Taira J; Kida Y; Yamaguchi H; Kuwano K; Higashimoto Y; Kodama H
J Pept Sci; 2010 Nov; 16(11):607-12. PubMed ID: 20648478
[TBL] [Abstract][Full Text] [Related]
22. Synthetic cationic amphiphilic α-helical peptides as antimicrobial agents.
Wiradharma N; Khoe U; Hauser CA; Seow SV; Zhang S; Yang YY
Biomaterials; 2011 Mar; 32(8):2204-12. PubMed ID: 21168911
[TBL] [Abstract][Full Text] [Related]
23. [Characteristic of AMP and the effects of chemical modifications on the modulation of their antimicrobial properties].
Makowska M; Prahl A; Małuch I
Postepy Biochem; 2019 Nov; 65(4):278-288. PubMed ID: 31945282
[TBL] [Abstract][Full Text] [Related]
24. Optimizing antimicrobial host defense peptides.
Sahl HG
Chem Biol; 2006 Oct; 13(10):1015-7. PubMed ID: 17052605
[TBL] [Abstract][Full Text] [Related]
25. Antimicrobial Peptides: An Approach to Combat Resilient Infections.
Parai D; Dey P; Mukherjee SK
Curr Drug Discov Technol; 2020; 17(4):542-552. PubMed ID: 31250760
[TBL] [Abstract][Full Text] [Related]
26. Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents.
Conlon JM; Al-Ghaferi N; Abraham B; Leprince J
Methods; 2007 Aug; 42(4):349-57. PubMed ID: 17560323
[TBL] [Abstract][Full Text] [Related]
27. Cationic host defense (antimicrobial) peptides.
Brown KL; Hancock RE
Curr Opin Immunol; 2006 Feb; 18(1):24-30. PubMed ID: 16337365
[TBL] [Abstract][Full Text] [Related]
28. The expanding scope of antimicrobial peptide structures and their modes of action.
Nguyen LT; Haney EF; Vogel HJ
Trends Biotechnol; 2011 Sep; 29(9):464-72. PubMed ID: 21680034
[TBL] [Abstract][Full Text] [Related]
29. Lipo-γ-AApeptides as a new class of potent and broad-spectrum antimicrobial agents.
Niu Y; Padhee S; Wu H; Bai G; Qiao Q; Hu Y; Harrington L; Burda WN; Shaw LN; Cao C; Cai J
J Med Chem; 2012 Apr; 55(8):4003-9. PubMed ID: 22475244
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial β-peptides and α-peptoids.
Godballe T; Nilsson LL; Petersen PD; Jenssen H
Chem Biol Drug Des; 2011 Feb; 77(2):107-16. PubMed ID: 21266014
[TBL] [Abstract][Full Text] [Related]
31. Applications of antimicrobial peptides from fish and perspectives for the future.
Rajanbabu V; Chen JY
Peptides; 2011 Feb; 32(2):415-20. PubMed ID: 21093512
[TBL] [Abstract][Full Text] [Related]
32. [Research Progress in Preparation of Antimicrobial Peptides and Their Mechanisms of Action].
Li Y; Wang J; Sun H
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Apr; 32(2):465-9. PubMed ID: 26211273
[TBL] [Abstract][Full Text] [Related]
33. The antibacterial peptide ABP-CM4: the current state of its production and applications.
Li JF; Zhang J; Xu XZ; Han YY; Cui XW; Chen YQ; Zhang SQ
Amino Acids; 2012 Jun; 42(6):2393-402. PubMed ID: 21805135
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial Mechanisms and Clinical Application Prospects of Antimicrobial Peptides.
Li X; Zuo S; Wang B; Zhang K; Wang Y
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566025
[TBL] [Abstract][Full Text] [Related]
35. Discovery of Trp-His and His-Arg analogues as new structural classes of short antimicrobial peptides.
Sharma RK; Reddy RP; Tegge W; Jain R
J Med Chem; 2009 Dec; 52(23):7421-31. PubMed ID: 19655779
[TBL] [Abstract][Full Text] [Related]
36. Purification and properties of antimicrobial peptides from skin secretions of the Eritrea clawed frog Xenopus clivii (Pipidae).
Conlon JM; Mechkarska M; Ahmed E; Leprince J; Vaudry H; King JD; Takada K
Comp Biochem Physiol C Toxicol Pharmacol; 2011 Apr; 153(3):350-4. PubMed ID: 21199684
[TBL] [Abstract][Full Text] [Related]
37. Susceptibility of Neisseria gonorrhoeae to antimicrobial peptides from amphibian skin, dermaseptin, and derivatives.
Zairi A; Tangy F; Ducos-Galand M; Alonso JM; Hani K
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):319-24. PubMed ID: 17254733
[TBL] [Abstract][Full Text] [Related]
38. Current and future challenges in the development of antimicrobial agents.
Rennie RP
Handb Exp Pharmacol; 2012; (211):45-65. PubMed ID: 23090595
[TBL] [Abstract][Full Text] [Related]
39. In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.
Romani AA; Baroni MC; Taddei S; Ghidini F; Sansoni P; Cavirani S; Cabassi CS
J Pept Sci; 2013 Sep; 19(9):554-65. PubMed ID: 23893489
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial peptides as potential tool to fight bacterial biofilm.
Dawgul M; Maciejewska M; Jaskiewicz M; Karafova A; Kamysz W
Acta Pol Pharm; 2014; 71(1):39-47. PubMed ID: 24779193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
